TransCon PTH is a prodrug of parathyroid hormone (PTH [1-34]), administered once daily, designed to provide continuous exposure to released PTH over the 24-hour dosing period.

Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical stage biopharmaceutical company developing targeted protein modulation drugs designed to treat patients with cancer and inflammatory diseases, today ...

Blackstone's $100 billion-plus bet on data centers requires skilled labor. Here's how the firm is investing in talent at ...

Roche said on Monday that three early-stage obesity and diabetes drug candidates from its acquisition of Carmot Therapeutics ...

Yang Suiyi’s Karst won best film in the Fei Mu Awards, while Ramon Zurcher’s The Sparrow In The Chimney won best film in the ...

From attractive EMIs to assured buyback guarantees, luxury carmakers have lined up a slew of offers to woo customers this ...

A Sri Lankan trade union leader and member of the island nation's new Marxist-leaning president's party has denied receiving ...

On the surface, the 50/25/25 rule is simple -- for any speech, no matter the type, venue, or timeline until delivery -- you ...

It's a 'Disaster' waiting to happen – and that's a good thing for all involved. Find out how the NZ debut of an immersive ...